Group 1 - The company, Ying Sheng Science (00209), announced that as of January 8, 2026, a total of 1.039 billion shares were validly accepted and applied for in the rights issue, representing approximately 79.92% of the total 1.3 billion shares available for subscription [1] - Due to insufficient subscriptions, approximately 261 million shares were not subscribed, accounting for about 20.08% of the total shares available for subscription [1] - Following the underwriting agreement, the underwriters facilitated the subscription of the 261 million shares, resulting in the total shares available for subscription being fully subscribed [1] Group 2 - The total amount raised from the rights issue is approximately HKD 182 million, with the estimated net proceeds after deducting underwriting commissions and other related expenses being around HKD 176.5 million [1]
瀛晟科学(00209)发行供股净筹约1.765亿港元